The study has three aims; firstly to establish if, having been informed of their risk status and that gene testing is inappropriate for them, low and moderate risk patients have misunderstood or failed to grasp this and want a test that is inappropriate for them. Secondly, to elicit patients' willingness to pay for cancer genetic services. Thirdly, to ascertain the aspects of cancer genetics services that are important to high risk patients and present service configurations prioritised in te...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Patient preferences and National Health Service costs: a cost-consequences analysis of cancer genetic services.
If you are the owner of this record, you can report an update to it here: Report update to this record